PALATIN TECHNOLOGIES INC PTN
- PL9643 — Dry Eye Disease Phase 3
- PL8177 — Ulcerative Colitis Phase 2
MC1R (2 companies · 3 programs)
Companies with an active program directed at MC1R.
Perspective Therapeutics, Inc. CATX
- lapemelanotide zapixetar — Melanoma Phase 1